Company Overview of Gryphon Therapeutics, Inc.
Gryphon Therapeutics, Inc. went out of business. Gryphon Therapeutics, Inc. develops polymer-modified proteins made by chemical synthesis. Its products combine chemically synthesized protein backbones with polyethylene glycols, such as molecules to create potent medications. Gryphon Therapeutics, Inc. was formerly known as Gryphon Sciences and changed its name in October, 2002. The company was founded in 1993 and is based in South San Francisco, California.
600 Gateway Boulevard
South San Francisco, CA 94080
Founded in 1993
Key Executives for Gryphon Therapeutics, Inc.
Gryphon Therapeutics, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Memcine Pharmaceuticals Inc.||United States|
|Antegrin Therapeutics LLC||United States|
|HemaCare BioScience, Incorporated||United States|
|Nutritional Laboratories International, Inc.||United States|
|RP Select Finance Trust||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Gryphon Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.